NADIMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
NADIMED
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2026 compared with 2025filed annual accounts (NBB)
Net result for the year
€112,140
2025 · €607,597-€495,456
Equity
€821,966
2025 · €1.2m-€402,334
Cash
€814,957
2025 · €1.7m-€858,110
Balance sheet total
€2.3m
2025 · €3.1m-€877,263
Largest movements
Assets
- Cash -€858,110
down €858,110 (-51.3%), from €1.7m to €814,957
mainly Other debts (-€641,738) and Contributions, distributions and other (-€514,475)
- Receivables within one year -€107,825
down €107,825 (-14.5%), from €741,735 to €633,909
of which Trade receivables: -€174,263
- Stocks and contracts +€102,987
up €102,987 (+23.0%), from €447,810 to €550,797
Equity and liabilities
- Other debts -€641,738
down €641,738 (-55.5%), from €1.2m to €514,475
- Reserves -€402,334
down €402,334 (-33.4%), from €1.2m to €803,366
of which Distributable reserves: -€402,334
- Trade debts +€113,011
up €113,011 (+16.1%), from €701,967 to €814,978
Income statement
- Goods and materials +€964,362
up €964,362 (+8.9%), from €10.8m to €11.8m
of which Purchases: +€1.2m
- Turnover +€858,022
up €858,022 (+7.0%), from €12.2m to €13.0m
- Financial income -€265,215
down €265,215 (-97.2%), from €272,989 to €7,774
- Staff costs +€218,471
up €218,471 (+91.6%), from €238,446 to €456,917
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2025
€607,597
Turnover
+€858,022
Other operating income
+€4,595
Goods and materials
-€964,362
Services and other goods
+€11,559
Staff costs
-€218,471
Depreciation
+€6,548
Write-downs
-€52,300
Other operating charges
-€353
Financial income
-€265,215
Financial charges
-€1,316
Taxes
+€125,837
Result 2026
€112,140
raises the resultlowers the result
Derived cash bridge
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€322,052
Investment
-€21,583
Financing
-€514,475
Cash 2025
€1.7m
From operations (derived)
-€322,052
Net result for the year
+€112,140
Depreciation
+€39,497
Stocks and contracts
-€102,987
Receivables within one year
+€107,825
Deferred charges and accrued income
-€3,599
Trade debts
+€113,011
Tax, wage and social debts
+€28,858
Other debts
-€641,738
Accrued charges and deferred income
+€24,940
Investment (derived)
-€21,583
Investment in fixed assets (net)
-€21,583
Financing
-€514,475
Contributions, distributions and other
-€514,475
Cash 2026
€814,957
brings cash intakes cash out
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €3,149,714 | €2,272,450 | -€877,263 | -27.9% |
| Fixed assets | 21/28 | €100,805 | €82,891 | -€17,914 | -17.8% |
| Tangible fixed assets | 22/27 | €85,205 | €64,737 | -€20,468 | -24.0% |
| Plant, machinery and equipment | 23 | €1,370 | €735 | -€635 | -46.4% |
| Furniture and vehicles | 24 | €7,050 | €3,909 | -€3,141 | -44.6% |
| Other tangible fixed assets | 26 | €76,785 | €60,093 | -€16,692 | -21.7% |
| Financial fixed assets | 28 | €15,600 | €18,154 | +€2,554 | +16.4% |
| Other financial fixed assets | 284/8 | €15,600 | €18,154 | +€2,554 | +16.4% |
| Amounts receivable and cash guarantees | 285/8 | €15,600 | €18,154 | +€2,554 | +16.4% |
| Current assets | 29/58 | €3,048,908 | €2,189,559 | -€859,349 | -28.2% |
| Stocks and contracts in progress | 3 | €447,810 | €550,797 | +€102,987 | +23.0% |
| Stocks | 30/36 | €447,810 | €550,797 | +€102,987 | +23.0% |
| Goods purchased for resale | 34 | €447,810 | €550,797 | +€102,987 | +23.0% |
| Amounts receivable within one year | 40/41 | €741,735 | €633,909 | -€107,825 | -14.5% |
| Trade receivables | 40 | €630,548 | €456,285 | -€174,263 | -27.6% |
| Other amounts receivable | 41 | €111,187 | €177,625 | +€66,438 | +59.8% |
| Current investments | 50/53 | €0 | - | = | |
| Other investments | 51/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €1,673,067 | €814,957 | -€858,110 | -51.3% |
| Deferred charges and accrued income | 490/1 | €186,297 | €189,896 | +€3,599 | +1.9% |
| Total equity and liabilities | 10/49 | €3,149,714 | €2,272,450 | -€877,263 | -27.9% |
| Equity | 10/15 | €1,224,301 | €821,966 | -€402,334 | -32.9% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,205,701 | €803,366 | -€402,334 | -33.4% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Tax-exempt reserves | 132 | €27 | €27 | = | 0.0% |
| Distributable reserves | 133 | €1,205,674 | €803,339 | -€402,334 | -33.4% |
| Amounts payable | 17/49 | €1,925,413 | €1,450,484 | -€474,929 | -24.7% |
| Amounts payable within one year | 42/48 | €1,893,278 | €1,393,409 | -€499,869 | -26.4% |
| Trade debts | 44 | €701,967 | €814,978 | +€113,011 | +16.1% |
| Suppliers | 440/4 | €701,967 | €814,978 | +€113,011 | +16.1% |
| Taxes, remuneration and social security | 45 | €35,098 | €63,956 | +€28,858 | +82.2% |
| Taxes | 450/3 | - | €174 | +€174 | |
| Remuneration and social security | 454/9 | €35,098 | €63,782 | +€28,685 | +81.7% |
| Other amounts payable | 47/48 | €1,156,213 | €514,475 | -€641,738 | -55.5% |
| Accrued charges and deferred income | 492/3 | €32,135 | €57,075 | +€24,940 | +77.6% |
| Operating income | 70/76A | €12,204,649 | €13,067,266 | +€862,617 | +7.1% |
| Turnover | 70 | €12,190,131 | €13,048,153 | +€858,022 | +7.0% |
| Other operating income | 74 | €14,519 | €19,113 | +€4,595 | +31.6% |
| Operating charges | 60/66A | €11,701,137 | €12,918,516 | +€1.2m | +10.4% |
| Goods for resale, raw materials and consumables | 60 | €10,832,570 | €11,796,932 | +€964,362 | +8.9% |
| Purchases | 600/8 | €10,715,189 | €11,952,219 | +€1.2m | +11.5% |
| Change in stocks: decrease (increase) | 609 | €117,381 | -€155,287 | -€272,669 | |
| Services and other goods | 61 | €582,870 | €571,312 | -€11,559 | -2.0% |
| Remuneration, social security and pensions | 62 | €238,446 | €456,917 | +€218,471 | +91.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €46,045 | €39,497 | -€6,548 | -14.2% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €52,300 | +€52,300 | |
| Other operating charges | 640/8 | €1,206 | €1,559 | +€353 | +29.3% |
| Operating profit (loss) | 9901 | €503,512 | €148,750 | -€354,762 | -70.5% |
| Financial income | 75/76B | €272,989 | €7,774 | -€265,215 | -97.2% |
| Recurring financial income | 75 | €272,989 | €7,774 | -€265,215 | -97.2% |
| Income from financial fixed assets | 750 | €0 | - | = | |
| Income from current assets | 751 | €114,838 | €7,647 | -€107,191 | -93.3% |
| Other financial income | 752/9 | €158,151 | €127 | -€158,024 | -99.9% |
| Financial charges | 65/66B | €1,706 | €3,021 | +€1,316 | +77.1% |
| Recurring financial charges | 65 | €1,706 | €3,021 | +€1,316 | +77.1% |
| Debt charges | 650 | - | €1,955 | +€1,955 | |
| Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals) | 651 | €0 | - | = | |
| Other financial charges | 652/9 | €1,706 | €1,066 | -€640 | -37.5% |
| Profit (loss) for the period before taxes | 9903 | €774,795 | €153,502 | -€621,293 | -80.2% |
| Income taxes | 67/77 | €167,198 | €41,361 | -€125,837 | -75.3% |
| Taxes | 670/3 | €167,198 | €41,361 | -€125,837 | -75.3% |
| Profit (loss) for the period | 9904 | €607,597 | €112,140 | -€495,456 | -81.5% |
| Transfer from tax-exempt reserves | 789 | €0 | - | = | |
| Profit (loss) for the period to be appropriated | 9905 | €607,597 | €112,140 | -€495,456 | -81.5% |
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.